Kaliumchlorid Orifarm

Potassium Chloride, the active ingredient in Kaliumchlorid Orifarm, is a potassium supplement presented as an oral formulation for oral use. It is employed to correct low serum potassium levels and to maintain electrolyte balance in patients who are at risk of hypokalemia or potassium deficiency.

GNH USA supplies Kaliumchlorid Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Kaliumchlorid Orifarm is a potassium supplement used to treat conditions associated with low serum potassium and related electrolyte disturbances.

- Hypokalemia: restores normal serum potassium levels to prevent muscle weakness and cardiac complications. - Potassium deficiency: replenishes depleted potassium stores during prolonged illness or diuretic therapy. - Prevention of cardiac arrhythmias: helps maintain cardiac electrical stability in patients with low potassium. - Support during diuretic therapy: compensates for potassium loss caused by loop or thiazide diuretics.

Kaliumchlorid Orifarm may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Nausea or vomiting: mild gastrointestinal upset after oral intake. - Abdominal discomfort: cramping or bloating in the stomach area. - Diarrhea: loose stools occurring shortly after dosing. - Metallic taste: transient alteration in oral sensation. - Hyperkalemia: elevated serum potassium when dosing exceeds needs. - Headache: mild, non‑specific head discomfort.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances in patients with excessive potassium. - Severe hyperkalemia: may lead to muscle paralysis or respiratory failure. - Allergic reaction: rash, itching, or swelling indicating hypersensitivity.

Before initiating therapy with Kaliumchlorid Orifarm, consider the following safety measures.

- Monitor serum potassium: check levels regularly to avoid over‑correction. - Assess renal function: impaired kidneys reduce potassium excretion and increase risk of accumulation. - Avoid use in hyperkalemia: contraindicated when serum potassium is already elevated. - Caution with ACE inhibitors or ARBs: these agents can potentiate potassium retention. - Review concomitant potassium‑sparing diuretics: combined use may precipitate hyperkalemia. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kaliumchlorid Orifarm can interact with several medicines that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause dangerous increases in serum potassium. - Potassium‑sparing diuretics (e.g., spironolactone): additive effect on potassium levels. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce renal potassium excretion.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hyperkalemia. - Digoxin: elevated potassium can alter digoxin toxicity risk. - Lithium: potassium shifts can affect lithium clearance and toxicity.